Cites Summit’24: a meeting to connect, share and project

During three intensive days of work, sixteen outstanding companies from our portfolio came together to participate in CITES SUMMIT ’24, an experience designed to address business challenges, generate connections and chart a strategic course towards the future.

Startups that participated include Viewmind, Teramot, Stradot, Selectivity, Radbio, PEPTON, Neuroacoustics, Imvalv, Gbot, Ergo Bioscience, Epiliquid, Eolo Pharma, Crinsurance, Clover, Bionirs. Which met in an environment of collaboration and creativity in Sunchales, Santa Fe, from March 11 to 13, 2024.

During the event, a comprehensive analysis of the challenges faced and progress made over the past year was carried out. In addition, strategic planning based on Objectives and Key Results (OKR) was implemented for the year 2024, with the aim of driving growth and innovation in all participating startups.

CITES SUMMIT ’24 not only offered a space for the exchange of ideas and business collaboration, but also featured three outstanding talks given by prominent business leaders: Pía Garat, CEO of Eolo Pharma, Mark Edwards, CEO of Viewmind , and Nicolás Kirchuk, CEO of BioMakers, shared their knowledge and experiences, inspiring attendees with innovative ideas and valuable perspectives.

Pamela Pardini CEO of BIONIRS, María Varela CEO of ARDAN PHARMA and María Pía Garat CEO of EOLO PHARMA

The event was a resounding success, marked by collaboration, innovation and commitment to business growth. CITES SUMMIT ’24 has laid the foundation for a promising future for all participating companies, further cementing CITES’ position as a key driver in company building.